QuickView for TNRC13;jsessionid=3D765BD25ABDC6EF1EDE0A75B9F1BD6C;jsessionid=F814328285108F7A4EA0DA28CFE696D7;jsessionid=502E776C630F24248151AAEED05D5B46;jsessionid=FE390919606FA9CDF00B0C61A4202833;jsessionid=3EE3EEB4A58206AB7EA024C65328ECD3;jsessionid=EC287E009D0EA95B3D121E6370F4ED32;jsessionid=EE1A9FFF6B3162C3B11CB20D5BC3D6E6;jsessionid=DD606EC75BBCB36379C9744C7E1B9591 (gene)

1. ATXN2 intermediate expansions in amyotrophic lateral sclerosis.
2. Missense mutation in ATXN2 gene (c.2860C > T) in an amyotrophic lateral sclerosis patient with aggre…
3. The RNA-binding protein and stress granule component ATAXIN-2 is expressed in mouse and human tissue…
4. Ataxin-2 gene: a powerful modulator of neurological disorders.
5. Antagonistic roles for Ataxin-2 structured and disordered domains in RNP condensation.

There were no clinical trials for TNRC13;jsessionid=3D765BD25ABDC6EF1EDE0A75B9F1BD6C;jsessionid=F814328285108F7A4EA0DA28CFE696D7;jsessionid=502E776C630F24248151AAEED05D5B46;jsessionid=FE390919606FA9CDF00B0C61A4202833;jsessionid=3EE3EEB4A58206AB7EA024C65328ECD3;jsessionid=EC287E009D0EA95B3D121E6370F4ED32;jsessionid=EE1A9FFF6B3162C3B11CB20D5BC3D6E6;jsessionid=DD606EC75BBCB36379C9744C7E1B9591